Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Ampio Pharmaceuticals stock

Own Ampio Pharmaceuticals stock in just a few minutes.

Ampio Pharmaceuticals, Inc is a biotechnology business based in the US. Ampio Pharmaceuticals shares (AMPE) are listed on the NYSE MKT and all prices are listed in US Dollars. Ampio Pharmaceuticals employs 18 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Ampio Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMPE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Ampio Pharmaceuticals share price

Use our graph to track the performance of AMPE stocks over time.

Ampio Pharmaceuticals shares at a glance

Information last updated 2021-04-30.
52-week range$0.45 - $2.98
50-day moving average $1.74
200-day moving average $1.48
Wall St. target price$4.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.01

Buy Ampio Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ampio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ampio Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -53.67%
Return on equity TTM -132.7%
Profit margin 0%
Book value $0.09
Market capitalisation $361.9 million

TTM: trailing 12 months

Shorting Ampio Pharmaceuticals shares

There are currently 19.9 million Ampio Pharmaceuticals shares held short by investors – that's known as Ampio Pharmaceuticals's "short interest". This figure is 0.2% down from 19.9 million last month.

There are a few different ways that this level of interest in shorting Ampio Pharmaceuticals shares can be evaluated.

Ampio Pharmaceuticals's "short interest ratio" (SIR)

Ampio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ampio Pharmaceuticals shares currently shorted divided by the average quantity of Ampio Pharmaceuticals shares traded daily (recently around 1.7 million). Ampio Pharmaceuticals's SIR currently stands at 11.85. In other words for every 100,000 Ampio Pharmaceuticals shares traded daily on the market, roughly 11850 shares are currently held short.

However Ampio Pharmaceuticals's short interest can also be evaluated against the total number of Ampio Pharmaceuticals shares, or, against the total number of tradable Ampio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ampio Pharmaceuticals's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Ampio Pharmaceuticals shares in existence, roughly 100 shares are currently held short) or 0.1028% of the tradable shares (for every 100,000 tradable Ampio Pharmaceuticals shares, roughly 103 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Ampio Pharmaceuticals.

Find out more about how you can short Ampio Pharmaceuticals stock.

Ampio Pharmaceuticals share dividends

We're not expecting Ampio Pharmaceuticals to pay a dividend over the next 12 months.

Have Ampio Pharmaceuticals's shares ever split?

Ampio Pharmaceuticals's shares were split on a 1:3 basis on 31 July 2008. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ampio Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Ampio Pharmaceuticals shares which in turn could have impacted Ampio Pharmaceuticals's share price.

Ampio Pharmaceuticals share price volatility

Over the last 12 months, Ampio Pharmaceuticals's shares have ranged in value from as little as $0.4535 up to $2.98. A popular way to gauge a stock's volatility is its "beta".

AMPE.US volatility(beta: 1.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ampio Pharmaceuticals's is 1.765. This would suggest that Ampio Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Ampio Pharmaceuticals overview

Ampio Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site